Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Analyst Says Company Could Be a 'Breakout Explorer Name in 2020'

A Cormark Securities report highlights that recent exploration by Troilus Gold yields one of the best holes ever drilled on the property. In an April 22 research note, Cormark Securities analyst Richard Gray reported that Troilus Gold Corp.'s (TLG:TSX; CHXMF:OTCQB...

Biotech's New Mesothelioma Trial Data Show Efficacy, Immunogenicity

These results of a study evaluating Targovax's lead candidate are reviewed and commented on in an H.C. Wainwright & Co. report. In a June 22 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Targovax ASA's (TRVX:OSE) ONCOS-102, in trial ...

Regenerative Medicine Firm Reports Early Results from COVID-19 Trials

Pluristem Therapeutics' coronavirus clinical studies and financing are discussed in a Dawson James report. In a June 11 research note, Dawson James analyst Jason Kolbert reported that Pluristem Therapeutics Inc. (PSTI:NASDAQ) announced the status of COVID-19-infe...

Immunotherapy Firm Releases Data Showing Treatment Potential Against Sepsis

Recently presented results from Enlivex Therapeutics' Phase 1b study in sepsis and their implications are reviewed in an H.C. Wainwright & Co. report. In a June 1 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Enlivex Therapeutics Ltd.'s ...

BARDA Award Provides 'Lift-off for Biotech's COVID Vaccine'

The ways in which Moderna is to use the funds are explained and an update on its coronavirus vaccine is provided in a ROTH Capital Partners report. In an April 19 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that the Biomedical Advanc...

Canadian Gold Miner Reports 'Q1/20 Production Beat'

The first quarter performance of Mandalay Resources' two operating mines is summarized and discussed in a BMO Capital Markets report. In an April 14 research note, BMO Capital Markets analyst Brian Quast reported that Mandalay Resources Corp. (MND:TSX) ach...

Ontario Mine On Track for First Gold Pour in Late 2020

The latest news and a construction update on Pure Gold Mining's Canadian project are provided in an Echelon Wealth Partners report. In a March 30 research note, Echelon Wealth Partners analyst Ryan Walker reported that Pure Gold Mining Inc. (PGM:TSX.V; PUR:LSE) r...

Facing Low Oil Prices, Energy Firm Reduces 2020 Capex, Guidance

The latest moves of Frontera Energy in response to depressed oil prices and its ability to endure the downturn are addressed in a CIBC report. In a March 23 research note, CIBC analyst Dave Popowich reported that Frontera Energy Corp. (FEC:TSX; FECCF:OTCMKT...

Potential Rerating Ahead for New Gold Producer

Why it is a good time to get into Lundin Gold stock and the company's major move in response to COVID-19 are covered in an Echelon Wealth Partners report. In a March 23 research note, Echelon Wealth Partners analyst Ryan Walker wrote that the big recent pull...

Silver & Gold Producer Achieves Solid Q4/19

An update on Fortuna Silver Mines is provided in a CIBC report. In a March 15 research note, CIBC analyst Cosmos Chiu reported that Fortuna Silver Mines Inc.'s (FSM:NYSE; FVI:TSX; FVI:BVL; F4S:FSE) Q4/19 financials were solid but the company increased cape...
1 2 3 4 5 6 7 8